XANTOS BIOMEDICINE AG innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	EPO (European Patent Office)	7
#2	WIPO (World Intellectual Property Organization)	7
#3	Australia	3
#4	Germany	3
#5	United States	2
#6	Canada	1

#	Technology
#1	Medical preparations
#2	Microorganisms
#3	Peptides
#4	Therapeutic chemical compounds
#5	Analysing materials
#6	Climate change adaptation technologies
#7	Measuring microorganism processes

Publication	Filing date	Title
EP1764109A1	2005-05-24	Agonist antibodies that bind to the TWEAK receptor Fn14, thereby modulating adiposity-associated phenotypes, and their use in therapy
EP1764371A1	2005-04-25	Agonist antibodies that bind to the LT-beta receptor, thereby modulating adiposity-associated phenotypes, and their use in therapy
WO2005053728A2	2004-12-01	Obesity-associated proteins and the use thereof in therapy and diagnosis
EP1670908A2	2004-10-01	Medical use of tbk-1 or of inhibitors thereof
WO2004111085A1	2004-06-09	Angiogenic factor and its medical use
WO2004072111A2	2004-02-12	Novel therapeutic and diagnostic apoptotic inductors
DE10362092A1	2003-12-01	Adiposity-associated proteins and their use in therapy and diagnostics
AU2003239851A1	2003-05-08	Expression constructs for producing double-stranded (ds) rna and the use thereof
AU2003235789A8	2003-01-13	Novel apoptosis-inducing dna sequences
EP1417306A2	2002-08-09	High-throughput dna-isolation and transfection for analysing the function of genes or genetic products
DE10125033A1	2001-05-22	Use of Sjoegren syndrome antigens as apoptotic targets, useful for diagnosis, treatment, e.g. of cancer or neurodegeneration, and drug screening
EP1248856A2	2000-12-21	Screening method for nucleic acids